Rajesh Garg, MD

Rajesh Garg, MD

Professor of Medicine, David Geffen School of Medicine at UCLA 
Investigator, The Lundquist Research Institute 

Contact

Email
rajesh.garg@lundquist.org

Research Description

Dr. Rajesh Garg is a professor of medicine at the David Geffen School of Medicine and the Head of Diabetes Section at the Harbor-UCLA Medical Center. He was previously an Associate Professor of Medicine at the Brigham and Women's Hospital, Harvard Medical School in Boston, and then a Professor of Medicine and Director of Clinical Diabetes at the University of Miami. His research interests include diabetes, obesity, insulin resistance and cardiovascular disease. In addition, Dr. Garg has completed an immense amount of research work to improve the clinical care of patients with diabetes. He has published more than a hundred articles on issues related to diabetes and edited two books on the management of diabetes and endocrinology. He was instrumental in creating standards of clinical care for preoperative management of diabetes for elective surgery patients. He led the comprehensive diabetes center at the University of Miami and designed the clinical diabetes program for Jackson Memorial Hospital in Miami before moving to LA where he is focused on improving diabetes care of the under-resourced populations. He is a nationally recognized expert on diabetes and serves on many national and international professional committees.

Education

  • MBBS, 1987, Government Medical College, Patiala, India
  • MD, 1991 SMS Medical College, Jaipur, India
  • DM, 1996, All India Institute of Medical Sciences, New Delhi, India
  • Resident, 1999-2001, Cornell University, Brooklyn, New York
  • Clinical Fellow, 2001-2003, SUNY, Buffalo, New York

Recent and/or Significant Publications

Wexler DJ, de Boer IH, Ghosh A, Younes N, Bebu I, Inzucchi SE, McGill JB, Mudaliar S, Schade D, Steffes MW, Tamborlane WV, Tan MH, Ismail-Beigi F. Comparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 Diabetes: The GRADE Randomized Clinical Trial. JAMA Intern Med. 2023 Jul 1;183(7):705-714.
PubMed
Pagidipati NJ, Nelson AJ, Kaltenbach LA, Leyva M, McGuire DK, Pop-Busui R, Cavender MA, Aroda VR, Magwire ML, Richardson CR, Lingvay I, Kirk JK, Al-Khalidi HR, Webb L, Gaynor T, Pak J, Senyucel C, Lopes RD, Green JB, Granger CB. Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes: A Randomized Clinical Trial. JAMA. 2023 Apr 18;329(15):1261-1270.
PubMed
Gulanski BI, Butera NM, Krause-Steinrauf H, Lichtman JH, Harindhanavudhi T, Green JB, Suratt CE, AbouAssi H, Desouza C, Ahmann AJ, Wexler DJ, Aroda VR. Higher burden of cardiometabolic and socioeconomic risk factors in women with type 2 diabetes: an analysis of the Glycemic Reduction Approaches in Diabetes (GRADE) baseline cohort. BMJ Open Diabetes Res Care. 2023 Apr;11(2).
PubMed
Brodar KE, La Greca AM, Leite RO, Marchetti D, Jaramillo M, Luzuriaga M, Garg R, Saab P. Patient and Provider Views on Psychosocial Screening in a Comprehensive Diabetes Center. J Clin Psychol Med Settings. 2023 Mar;30(1):92-110.
PubMed Central
Valderrábano RJ, Badour S, Ferri-Guerra J, Barb D, Garg R. Body Fat Distribution in Lean Individuals with Metabolic Abnormalities. Metab Syndr Relat Disord. 2023 Mar;21(2):79-84
PubMed